Jul 2026· Cell Death and Differentiation· 0 citations· 42 references
Medicine
TL;DR
A snoRNA-chromatin-repair axis driving therapeutic resistance and support SNORA23 inhibition as a promising strategy to overcome radioresistance in ESCC are defined.
Abstract
Radioresistance remains a major barrier in esophageal squamous cell carcinoma (ESCC). This study demonstrates small nucleolar RNA SNORA23 as a pathogenic epigenetic driver of intrinsic radioresistance, with its overexpression tightly correlating with advanced T-stage, lymph node metastasis, and adverse clinical outcomes in a chemoradiotherapy cohort. Mechanistically, SNORA23 directly binds the ARID domain of histone demethylase KDM5C via a structurally defined G11-Ser169 interface-obstructing KDM5C chromatin binding to derepress DNA repair scaffolding gene SFPQ. This chromatin reprogramming enables SFPQ-facilitated recruitment of RAD51 and Ku80 to DNA double-strand breaks, accelerating homologous recombination (HR) and non-homologous end joining (NHEJ). SFPQ high expression recapitulates SNORA23-mediated repair enhancement and reduced radiosensitivity. Therapeutically, SNORA23-targeting antisense oligonucleotides (ASOs) disrupt this axis, impair DNA repair, and synergize with radiotherapy to suppress tumor growth and prolong survival in vivo without evident systemic toxicity These findings define a snoRNA-chromatin-repair axis driving therapeutic resistance and support SNORA23 inhibition as a promising strategy to overcome radioresistance in ESCC.
This work defines the ITGA5/FAK/β-catenin/MYC/RAD51AP1 pathway as a key mechanistic driver of radioresistance and validates ITGA5 as a potential clinical target for ESCC therapy.
ABSTRACT Radioresistance remains a significant challenge in the radiotherapy (RT) of head and neck squamous cell carcinoma (HNSCC). However, the biological factors that govern sensitivity to this therapy are not well‐understood. The DEAD‐box family is known for its role in genome stability, and inextricably linked to t...
Tian-Ru Yang, T. Shen, Yan-Fang Qiu et al.· Advancement of science· 0 citations
The hypothesis emphasizes the need to clarify the molecular mechanisms and signaling pathways associated with KAT8–H4K16ac, especially in relation to apoptotic pathways, which could offer new insights and justifications for treatment strategies in cisplatin‐resistant osteosarcoma.
Zhen-Qun Zhao, Guohui Yu, Shi-Kui Wu et al.· Med Research· 0 citations
These findings establish AR phase separation as a fundamental mechanism driving GC pathogenesis and propose co-targeting AR condensates and chromatin remodeling as a translatable therapeutic strategy.
Hua-Huan Liu, Yan-Xin Yao, Xiang-Nan Zhang et al.· Cell Death & Disease· 0 citations
An integrated mechanism in which SUMOylation-dependent stabilization of SEPT5 and UBE3B-mediated GSDME degradation converge to suppress pyroptosis and attenuate antitumor immunity is defined, positioning the SEPT5 regulatory axis as a potential therapeutic vulnerability to overcome radioresistance and enhance the effic...
Jun-Miao Wen, Wang Zheng, Bo-Yan Wang et al.· International Immunopharmaco...· 0 citations